Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Kyohei Yugawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3776-7913; OpenAlex author ID A5058277444. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-023-02675-z↗
  2. Impact of Capicua on Pancreatic Cancer Progression. Co-author DOI 10.1245/s10434-020-09339-z↗
  3. Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.07.011↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masaki Mori · 2 shared papers, 2020–2021 · strength 0.21
  2. Yoshinao Oda · 2 shared papers, 2020–2021 · strength 0.21
  3. Tomoharu Yoshizumi · 2 shared papers, 2020–2021 · strength 0.21
  4. Shinji Itoh · 2 shared papers, 2020–2021 · strength 0.21
  5. Shohei Yoshiya · 2 shared papers, 2020–2021 · strength 0.21
  6. Kenkichi Hashimoto · 1 shared paper, 2023 · strength 0.19
  7. Toru Ikegami · 1 shared paper, 2020 · strength 0.09
  8. Keishi Sugimachi · 1 shared paper, 2020 · strength 0.09
  9. Shoichi Inokuchi · 1 shared paper, 2020 · strength 0.09
  10. Tomohiro Iguchi · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.